Pharma Insights Firm Integro Hires Innovation Leader

In New York, healthcare insights agency Integro has appointed former Pfizer and Hall & Partners researcher Ariella Evenzahav as Head of Innovation.

Integro was formed two years ago by three former execs of Hall & Partners and Basis Health - Nicola Harte, Scott Kressner and Soumya Roy - with a focus on four areas: exploring deeper emotions, explaining behavioral change, providing 'actionability' from research, and delivering 'fast and agile' solutions.

Evenzahav (pictured) brings twenty years of experience in the pharmaceuticals sector, focusing on market insights, forecasting and commercial strategy. She spent nine years at Pfizer, mostly in Director roles and with a focus on oncology products, and two and a half years over two spells in the Oncology Centre of Excellence at Hall & Partners. She has also worked at Takeda, Karyopharm and most recently BeiGene, as well as running her own consultancy. She holds a PhD in Chemistry from Columbia University and a postdoctoral qualification from NYU.

Soumya Roy, Founding Partner at Integro, comments: 'We're beyond excited to have Ariella on board - her deep expertise and fresh ideas will be invaluable to our clients. We look forward to the impact she will make'.

Web site: www.thinkintegro.com .